Cargando…
M6A methylation modification in autoimmune diseases, a promising treatment strategy based on epigenetics
BACKGROUND: N6-methyladenosine (m6A) methylation modification is involved in the regulation of various biological processes, including inflammation, antitumor, and antiviral immunity. However, the role of m6A modification in the pathogenesis of autoimmune diseases has been rarely reported. METHODS:...
Autores principales: | Huang, Yurong, Xue, Qiuyun, Chang, Jun, Wang, Yuting, Cheng, Chenglong, Xu, Suowen, Wang, Xiao, Miao, Chenggui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544321/ https://www.ncbi.nlm.nih.gov/pubmed/37784134 http://dx.doi.org/10.1186/s13075-023-03149-w |
Ejemplares similares
-
RNA methylations in hepatic fibrosis, a gradually emerging new treatment strategy
por: Cheng, Chenglong, et al.
Publicado: (2023) -
RNA Methylations in Cardiovascular Diseases, Molecular Structure, Biological Functions and Regulatory Roles in Cardiovascular Diseases
por: Zhou, Wanwan, et al.
Publicado: (2021) -
N(6)-methyl-adenosine (m(6)A) in RNA: An Old Modification with A Novel Epigenetic Function
por: Niu, Yamei, et al.
Publicado: (2013) -
Epigenetic modification of m(6)A regulator proteins in cancer
por: Wang, Yumin, et al.
Publicado: (2023) -
m6A RNA Methylation in Systemic Autoimmune Diseases—A New Target for Epigenetic-Based Therapy?
por: Wardowska, Anna
Publicado: (2021)